161.76
price up icon0.12%   0.19
 
loading
Precedente Chiudi:
$161.57
Aprire:
$161.73
Volume 24 ore:
468.86K
Relative Volume:
0.35
Capitalizzazione di mercato:
$22.56B
Reddito:
$1.53B
Utile/perdita netta:
$-214.69M
Rapporto P/E:
-91.91
EPS:
-1.76
Flusso di cassa netto:
$-43.68M
1 W Prestazione:
-3.81%
1M Prestazione:
+1.01%
6M Prestazione:
-3.48%
1 anno Prestazione:
+44.89%
Intervallo 1D:
Value
$160.72
$163.17
Intervallo di 1 settimana:
Value
$158.00
$170.48
Portata 52W:
Value
$92.14
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Nome
Natera Inc
Name
Telefono
650-249-9090
Name
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Name
Dipendente
4,434
Name
Cinguettio
@nateragenetics
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
NTRA's Discussions on Twitter

Confronta NTRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
NTRA
Natera Inc
161.76 22.56B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
429.33 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
203.20 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
547.01 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
121.38 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
164.24 27.64B 15.50B 1.33B 2.16B 7.34

Natera Inc Stock (NTRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato RBC Capital Mkts Outperform
2025-01-23 Iniziato Barclays Overweight
2024-06-03 Ripresa Jefferies Buy
2024-04-08 Ripresa Craig Hallum Buy
2024-02-20 Downgrade Raymond James Strong Buy → Outperform
2023-12-29 Reiterato BTIG Research Buy
2023-12-14 Iniziato Guggenheim Buy
2023-12-13 Iniziato Wolfe Research Outperform
2023-11-13 Aggiornamento Raymond James Outperform → Strong Buy
2023-09-28 Iniziato Bernstein Mkt Perform
2023-07-05 Ripresa JP Morgan Overweight
2023-05-05 Iniziato UBS Buy
2023-01-18 Aggiornamento Raymond James Mkt Perform → Outperform
2022-08-25 Iniziato Credit Suisse Outperform
2022-04-25 Iniziato Stephens Overweight
2022-03-08 Iniziato Goldman Buy
2022-01-06 Ripresa Piper Sandler Overweight
2021-10-15 Ripresa Cowen Outperform
2021-06-15 Iniziato Raymond James Mkt Perform
2021-05-25 Iniziato Wells Fargo Overweight
2021-01-28 Iniziato Truist Buy
2020-10-08 Iniziato BTIG Research Buy
2020-09-28 Iniziato Morgan Stanley Overweight
2020-09-17 Iniziato SVB Leerink Outperform
2020-06-10 Ripresa Piper Sandler Overweight
2020-05-07 Aggiornamento JP Morgan Neutral → Overweight
2018-10-05 Iniziato JP Morgan Neutral
2018-07-05 Reiterato Piper Jaffray Overweight
2017-08-07 Reiterato Morgan Stanley Overweight
2016-11-10 Reiterato The Benchmark Company Buy
2016-05-23 Reiterato The Benchmark Company Buy
2016-05-11 Reiterato The Benchmark Company Buy
2016-04-19 Iniziato The Benchmark Company Buy
2015-09-28 Aggiornamento Wedbush Neutral → Outperform
2015-08-14 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2015-08-04 Iniziato Robert W. Baird Outperform
2015-07-27 Iniziato Morgan Stanley Equal-Weight
2015-07-27 Iniziato Piper Jaffray Overweight
2015-07-27 Iniziato Wedbush Neutral
Mostra tutto

Natera Inc Borsa (NTRA) Ultime notizie

pulisher
Jun 18, 2025

Natera Approves Equity Plan Amendment at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

DNA Testing Market Size, Share, and Forecast 2025-2033: Key - openPR.com

Jun 18, 2025
pulisher
Jun 17, 2025

Natera: Growth Likely To Moderate, Despite Signatera Test Medicare Coverage (NASDAQ:NTRA) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 16, 2025

Non-Invasive Cancer Testing Market Forecast | Major Players: Guardant Health, Exact Sciences, Qiagen, Natera Inc. - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Where are the Opportunities in (NTRA) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 13, 2025

Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Insider Sell: Gail Marcus Sells 4,000 Shares of Natera Inc (NTRA) - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Natera, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 02 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Prenatal Genetic Counselling Market 2025-2032: Top Trends & - openPR.com

Jun 10, 2025
pulisher
Jun 09, 2025

Natera at Goldman Sachs Conference: Strategic Growth and Expansion - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Natera at Goldman Sachs Conference: Strategic Growth and Expansion By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 05, 2025

Insider Sell: Steven Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Colorectal Cancer Diagnostics Market Size To Boom with Top Key - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Natera stock gains after Leerink Partners reiterates outperform rating By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Natera's Signatera test to be covered under Medicare - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Medicare expands coverage for Natera’s Signatera MRD test By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Inc (NTRA) Trading 4.28% Higher on Jun 4 - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera (NTRA) Gains Medicare Coverage for Genome-Based Cancer Te - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera stock gains after Leerink Partners reiterates outperform rating - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera's Signatera test to be covered under Medicare (NTRA:NASDAQ) - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

Natera, Inc. Announces Medicare Coverage for Signatera Genome - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Natera (NTRA) Secures Medicare Coverage for Signatera MRD Assay | NTRA Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera announces Medicare coverage for Signatera MRD assay - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Medicare expands coverage for Natera’s Signatera MRD test - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera™ Genome | NTRA Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera ™ Genome - Business Wire

Jun 04, 2025
pulisher
Jun 04, 2025

Natera Announces Medicare Coverage for Signatera™ Genome - New Castle News

Jun 04, 2025
pulisher
Jun 03, 2025

Natera (NasdaqGS:NTRA) Showcases 94% Sensitivity In Pan-Cancer Signatera Genome Study - simplywall.st

Jun 03, 2025
pulisher
Jun 02, 2025

SignateraTM Genome Clinical Performance Highlighted at ASCO 2025 - GuruFocus

Jun 02, 2025
pulisher
May 31, 2025

Natera Inc.: Is The Recent Growth in Signatera Volumes Here To Stay? - Smartkarma

May 31, 2025
pulisher
May 27, 2025

Natera Inc (NTRA) Shares Up 3.07% on May 27 - GuruFocus

May 27, 2025
pulisher
May 26, 2025

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga

May 26, 2025
pulisher
May 24, 2025

When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com

May 24, 2025
pulisher
May 23, 2025

Natera Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

May 23, 2025
pulisher
May 22, 2025

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting | NTRA Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Natera raises 2025 revenue outlook to $1.94B-$2.02B with 26% growth target - MSN

May 22, 2025
pulisher
May 22, 2025

Transcript : Natera, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 10 - marketscreener.com

May 22, 2025
pulisher
May 19, 2025

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

May 19, 2025
pulisher
May 19, 2025

Stocks Showing Rising Market Leadership: Natera Earns 82 RS Rating - Investor's Business Daily

May 19, 2025
pulisher
May 18, 2025

There's Reason For Concern Over Natera, Inc.'s (NASDAQ:NTRA) Price - simplywall.st

May 18, 2025
pulisher
May 17, 2025

Natera (NASDAQ:NTRA) Rating Lowered to “Sell” at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

Natera (NASDAQ:NTRA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

May 17, 2025
pulisher
May 16, 2025

Natera: The Clues In Q1 Earnings (NASDAQ:NTRA) - Seeking Alpha

May 16, 2025
pulisher
May 15, 2025

NTRA: Piper Sandler Raises Price Target for Natera | NTRA Stock News - GuruFocus

May 15, 2025

Natera Inc Azioni (NTRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research LH
$261.89
price up icon 0.73%
diagnostics_research WAT
$350.22
price down icon 0.48%
diagnostics_research MTD
$1,209.08
price up icon 0.28%
diagnostics_research DGX
$176.92
price up icon 0.18%
diagnostics_research IQV
$164.24
price down icon 0.25%
Capitalizzazione:     |  Volume (24 ore):